Introduction
Antigen recognition by the T cell antigen receptor (TCR) and the B cell antigen receptor (BCR) initiates signals for activation, cell differentiations, and effector function via the noncovalently associating transmembrane (TM) adaptor molecules CD3γ, CD3δ, CD3ε, and ζ subunits of the TCR and α and β subunits of BCR, respectively. These adapter proteins bear immunoreceptor tyrosine-based activation motifs (ITAM) in their cytoplasmic regions, which are tyrosine phosphorylated by src family protein tyrosine kinases (PTKs) after antigen recognition, resulting in activation of down stream signaling molecules.
Fc receptors, including the high affinity IgE receptor (FcεRI), the IgG receptors (FcγRI, III, and IV) and the receptor for IgA (FcαRI; CD89), also associate with the ITAMbearing adapter FcRγ chain that is responsible for Fc receptor-mediated cell activation (1).
FcRγ chain is also an adapter that associates with several myeloid cell-specific receptors, including mouse PIR-A (2, 3) and human ILT-1 (4) and ILT-7 (5).
DAP12 (6) , also named killer-cell activating receptor-associated protein (KARAP) (7) , is another family member of ITAM-containing TM adapter proteins. DAP 12 is expressed in NK cells and associates with several activating NK receptors (reviewed in (8)), and is also expressed in myeloid cells. Several myeloid cell-specific receptors that associate with DAP12 have been reported, including human and mouse TREM-1, TREM-2, MDL-1, and PILRβ, human SIRPβ, and mouse TREM-3 and CD200RLa (reviewed in (9)).
We have recently identified paired activating and inhibitory immunoglobulin-like receptors, designated myeloid-associated immunoglobulin-like receptor (MAIR)-I and MAIR-II, whose extracellular domains are highly conserved with each other (10). MAIR-I, also named LMIR-1 (11) or CMRF-35-like molecule (CLM)-8 (12), contains immunoreceptor tyrosine-based inhibitory motifs (ITIM) in its cytoplasmic domain, and inhibits IgE-mediated degranulation of mast cells (10, 13). On the other hand, MAIR-II, also named LMIR-II (11), CLM-4 (12) or DIgR1 (14) , is expressed on subsets of peritoneal macrophages and B cells and associates with DAP12, which mediates activating signals, resulting in inflammatory cytokine secretion from macrophages (10). By screening a macrophage cDNA library and the mouse genome, we and another group found that MAIR-I and MAIR-II are members of a multigene family consisting of at least 9 genes on a small segment of mouse chromosome 11 (our unpublished observation and (12)). MAIR family genes are most similar to the human CD300 family (CMRF), which is located on human chromosome 17 (15) , syntenic region of mouse chromosome 11.
The family of TM adapter proteins described above are all characterized by a small extracellular region, an aspartic acid (D), a negatively charged amino acid, in the TM domain, and a cytoplasmic domain that contains one or more ITAM (16) . Receptors that associate with these TM adapters have a positively charged amino acid, such as lysine (K) or arginine (R), in their TM region and possess short cytoplasmic regions without any signaling motif.
Certain activating immune receptors expressed on lymphoid and myeloid cells selectively associate either with DAP12 or FcRγ; however, there is not prior evidence that a receptor can pair with both of these adapter proteins. We demonstrate here that MAIR-II physically and functionally associates with not only DAP12 but also FcRγ chain in peritoneal macrophages.
Materials and Methods

Mice
C57BL/6J mice were purchased from Clea (Tokyo, Japan). DAP12-deficient and FcRγ chain-deficient mice were previously described (17, 18) . These mutant mice were backcrossed to C57BL/6J mice for nine generations. All experiments were performed according to the guidelines of the animal ethics committee of the University of Tsukuba animal research center.
Cells and transfectant
Mouse peritoneal macrophages were collected by peritoneal lavage with 5 ml of PBS from 8 to 12 week old mice before or three days after i.p. injection of 2 ml of 4% sterile thioglycollate. B cells and macrophages from the spleen and peritoneal cavity were purified by using a MACS selection system with biotin-conjugated anti-B220 mAb and 
Antibodies
Control rat IgGs, anti-CD11b and anti-CD16/CD32 2.4G2 mAbs were purchased from BD Biosciences (San Jose, CA); anti-phosphotyrosine (4G10) and anti FcεRIγ (FcRγ chain) mAbs were purchased from Upstate Biotechnology (Lake Placid, NY); antip42/44 ERK and anti-phospho p42/44 ERK were purchased from Cell Signaling (Beverly, MA); and rabbit anti-Flag polyclonal antibody was purchased from SigmaAldrich. Anti-mouse DAP12 polyclonal antibody was a gift from M. Ono (Tohoku University School of Medicine, Sendai, Japan). TX52 (anti-MAIR-II) mAb was generated in our laboratory as described previously (10). F(ab') 2 fragments of TX52 mAb were prepared, as described previously (10). Purity of the F(ab') 2 fragments were determined by SDS-PAGE. To exclude LPS contamination, antibodies were treated with polymixin B (10 ug/ml; Sigma Aldrich) before use.
Biochemistry
Cells were lysed in 1% digitonin (Calbiochem, San Diego, CA), 0. 
Statistics
Statistical analyses were performed by unpaired Student's t-test.
RESULTS
MAIR-II mediates pro-inflammatory cytokine production from DAP12-deficient peritoneal macrophages
We previously demonstrated that MAIR-II was co-immunoprecipitated with DAP12, but not FcRγ chain, in primary spleen cells (10). Because MAIR-II was expressed on subsets of B cells and macrophages in spleen, we first examined whether MAIR-II associated with DAP12 either in B cells, macrophages or both. We demonstrate that MAIR-II was co-immunoprecipitated with DAP12 in both B220 + B cells and CD11b + macrophages purified from spleen ( Fig. 1) . Further experiments showed similar results in B220 + B cells and CD11b + macrophages purified from peritoneal exudative cells (PEC) (Fig. 1) , suggesting that DAP12 is a physiological partner of MAIR-II in B cells and macrophages in the spleen and peritoneal cavity. In fact, whereas splenic macrophages from WT mice produced TNF-α when stimulated with F(ab') 2 fragments of anti-MAIR-II mAb, DAP12-/-macrophages did not respond to the antibody stimulation for TNF-α secretion (Fig. 2) , indicating that DAP12 is required for MAIR-II-mediated activating signal in splenic macrophages. Unexpectedly, however, cross-linking MAIR-II produced significant amount of both TNF-α and IL-6 from DAP12-/-as well as WT peritoneal macrophages (Fig. 2) . These results suggest that another MAIR-II-associating adapter molecule, in addition to DAP12, may mediate activating signals specifically in peritoneal macrophages.
MAIR-II associates with FcRγ chain as well as DAP12 in peritoneal macrophages
Because B cells and macrophages express FcRγ chain as well as DAP12 (10), we investigated whether MAIR-II also associates with FcRγ chain in these cells from the spleen and PEC. We observed co-immunoprecipitation of MAIR-II with FcRγ chain in lysates of peritoneal macrophages and bone marrow-derived cultured macrophages ( Fig.   1 ). Moreover, it was significantly enhanced after culture of peritoneal macrophages in the presence of LPS (Fig. 1) , suggesting that not only DAP12 but also FcRγ chain associates with MAIR-II in peritoneal macrophages. In contrast, association of MAIR-II with FcRγ chain was not detected in splenic B cells and macrophages and peritoneal B cells, even after culture in the presence of LPS (Fig. 1) .
MAIR-II mediates activating signals through both DAP12 and FcRγ chain in peritoneal macrophages
The (Fig. 3A) . Consistent with these signaling events, cross-linking MAIR-II also induced TNF-α and IL-6 productions from WT, DAP12-/-, and FcRγ-/-peritoneal macrophages, but not from DKO mice (Fig. 3B) . Taken together, these results suggest that both DAP12 and FcRγ chain are responsible for MAIR-II-mediated activating signals in peritoneal macrophages.
LPS enhances FcRγ chain-dependent cell surface expression of MAIR-II in peritoneal macrophages
We demonstrated that LPS enhanced the association of MAIR-II with FcRγ chain, but not DAP12 (Fig. 1) , suggesting that LPS up-regulates FcRγ chain expression, accelerating the complex formation and cell surface expression of MAIR-II and FcRγ chain. In fact, we found that overnight culture with LPS induced up-regulation of FcRγ chain expression in WT peritoneal macrophages (Fig. 4A) . In contrast, DAP12 expression was not affected by LPS in peritoneal macrophages (Fig. 4A) 
MAIR-II associates with DAP12 or FcRγ chain homodimers
To determine whether DAP12 and FcRγ can form heterodimers, we transfected a rat basophilic leukemia, RBL-2H3, which does not express MAIR-II and DAP12, but does FcRγ chain (21), with a MAIR-II-IRES-GFP construct together with Flag-tagged DAP12. Experiments were performed to examine whether both DAP12 and FcRγ chain were co-immunoprecipitated with MAIR-II by using anti-Flag or anti-FcRγ chain mAbs.
As demonstrated in 
The lysine residue in the TM region of MAIR-II is involved in association with both DAP12 and FcRγ chain
Because MAIR-II contains a lysine TM region, but not an arginine, in the TM region, a question was raised whether the lysine residue is involved in the association with FcRγ chain as well as DAP12. We generated WT and mutant MAIR-II cDNA, which encoded MAIR-II containing an alanine instead of the lysine in the TM region. These cDNA were introduced into the 2B4 and BW5147 mouse T cell transfectants stably expressing (Fig. 6C) . Together, these results indicated that the lysine residue in the TM region of MAIR-II was involved in the association with FcRγ chain as well as DAP12.
Discussion
We have presented here the first case of an activating receptor that uses either DAP12 or 
